Skip to main content

Real-time fluorescence imager improves breast cancer outcomes

breast cancer

The device allows surgeons to scan tissue within the surgical cavity to observe residual cancer cells. Image: National Institutes of Health

Developed by MIT spinout Lumicell, the handheld device uses cameras and light-sensitive imaging agents to reveal residual cancer cells

Register for FREE to keep reading

Join 15,000+ photonics professionals staying ahead with:

  • Exclusive insights, funding alerts & market trends
  • Curated newsletters and digital editions
  • Access to The Photonics100 list of R&D champions
  • Exclusive panels & roundtables for professional development
  • Technical White Papers & product updates to guide smarter decisions

Sign up now

Already a member? Log in here

Your data is protected under our privacy policy.

Electro Optics covers

 

Media Partners